Real-world evidence (RWE) bridges the gap between clinical trials and actual patient outcomes. Certara’s Real-World Evidence Services provide robust solutions across the entire product lifecycle, ensuring that your strategies are data-driven and scientifically sound.
Real-World Evidence Solutions
Impactful Real-World Evidence Solutions
Learn more about Real-World Evidence services
Why Real-World Evidence services are critical
Quantify opportunity
Understand unmet needs, treatment patterns, burden of illness, and market sizing.
Justify access
Conduct cost-effectiveness and budget impact analyses to substantiate access.
Measure performance
Evaluate outcomes, drug utilization, and safety through post-authorization studies.
Certara's unique approach to Real-World Evidence
With more than 100 years of collective expertise in the design and execution of real-world data studies, Certara offers best-in-class modeling and advanced analytics to deliver unparalleled insights. Our integrated approach ensures precision and reliability in addressing complex challenges.
Explore our offerings
Evidence gap analysis
Identify missing links in your data strategy.
Data source selection
Tailored data sources for optimal outcomes.
Advanced analytics
Accelerate decision-making with dynamic tools.
Meet our experts
1 / 2
Experts
2 / 2
Experts
Explore Related Resources
View allContact us heading
Certara’s team of experts is ready to help you navigate the design and execution of real-world data studies aimed to support peri- and post-approval discussions with stakeholders.
Trusted partner in pharmaceutical innovation
Decades of experience in data-driven solutions
Proven success in regulatory and market access strategies
Discover more services
Frequently Asked Questions
What is Real-World Evidence (RWE)?
RWE refers to the use of real-world data to evaluate the effectiveness and safety of a product outside of clinical trials.
How does Certara support RWE projects?
Certara offers end-to-end support, from data selection to advanced analytics, ensuring impactful results.
What types of Real-World Data Sources is Certara available to collect and analyze?
Electronic health records, ANSER datasets, administrative medical records, chart reviews, ad hoc surveys, observational studies and more.
Why is RWE important for regulatory decisions?
RWE provides insights into real-life applications of treatments, aiding in informed regulatory and market access strategies.
